Related Experiment Video

Updated: Jan 30, 2026

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

11.4K

Cardiomyocyte differentiation of mouse and human embryonic stem cells

C Mummery1, D Ward, C E van den Brink

  • 1Hubrecht Laboratory, Utrecht, The Netherland. christin@niob.knaw.nl

Journal of Anatomy
|May 30, 2002
PubMed

Insights

Researchers are exploring methods to differentiate pluripotent stem cells into transplantable cardiomyocytes for cardiac repair. Early findings suggest embryonic stem cells can yield immature cardiomyocytes, which will be tested in a myocardial infarction model.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Ischaemic heart disease is a major cause of death globally.
  • Cardiac ischaemia leads to irreversible cell damage and loss of heart function.
  • Cardiomyocyte transplantation is a potential strategy to regenerate damaged cardiac tissue.

Purpose of the Study:

  • To investigate methods for inducing pluripotent stem cells to differentiate into transplantable cardiomyocytes.
  • To characterize the cardiomyocytes derived from stem cells.
  • To evaluate the efficacy of these cardiomyocytes in restoring cardiac function post-myocardial infarction.

Main Methods:

  • Induction of pluripotent stem cells (embryonic stem cells and embryonal carcinoma cells) towards cardiomyocyte differentiation using an endoderm-like cell line.
  • Initial characterization of the differentiated cardiomyocytes.
  • Utilizing a mouse myocardial infarction model to assess functional recovery after transplantation.

Main Results:

  • An endoderm-like cell line successfully induced embryonal carcinoma cell differentiation into immature cardiomyocytes.
  • Preliminary results indicate human and mouse embryonic stem cells respond similarly.
  • Initial characterization of these stem cell-derived cardiomyocytes is presented.

Conclusions:

  • Stem cell differentiation holds promise for generating cardiomyocytes for cardiac repair.
  • Further studies are needed to confirm the therapeutic potential of these cells in vivo.
  • This research paves the way for testing stem cell-based therapies in a myocardial infarction model.

More Related Videos

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol12:21

Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol

Published on: July 25, 2016

11.1K
Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction10:46

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction

Published on: November 3, 2011

20.8K

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.1K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.4K